EYEGATE PHARMACEUTICALS INC - COM (EYEG)

CUSIP: 30233M107

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
1,805,534
Share change
-248,429
Total reported value
$1,932,000
Price per share
$1.07
Number of holders
15
Value change
-$270,033
Number of buys
8
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 30233M107?
CUSIP 30233M107 identifies EYEG - EYEGATE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EYEGATE PHARMACEUTICALS INC - COM (EYEG) as of Q4 2017

As of 31 Dec 2017, EYEGATE PHARMACEUTICALS INC - COM (EYEG) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,805,534 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, Vanguard Group Inc, Virtu Financial LLC, CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC, MACQUARIE GROUP LTD, IFP Advisors, Inc, CREDIT SUISSE AG/, WEDBUSH SECURITIES INC, and NORTHERN TRUST CORP. This page lists 15 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.